Press Enter to search · ESC to close

US Stocks

J&J to acquire Ollin Biosciences for up to $3.4B, deal could close Monday

Johnson & Johnson plans to acquire Ollin Biosciences for up to $3.4 billion, with the deal potentially closing as soon as Monday. The transaction would mark a multibillion-dollar bolt-on for the healthcare group. No further terms were disclosed in the report.

Share

Related News

新云社 share card
Long-press image above → Save to Photos / Share
Pitch us Feedback